» Articles » PMID: 31284335

Impact of Iliac Crest Bone Grafting on Postoperative Outcomes and Complication Rates Following Minimally Invasive Transforaminal Lumbar Interbody Fusion

Overview
Journal Neurospine
Date 2019 Jul 9
PMID 31284335
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The relationship between bone graft technique and postoperative outcomes for minimally invasive transforaminal lumbar interbody fusion (MIS TLIF) has not been well-defined. This study aims to determine the effect of iliac crest bone grafting (ICBG) on patient-reported outcomes (PROs) and complication rates following MIS TLIF.

Methods: Primary, single-level MIS TLIF patients were consecutively analyzed. Patients that prospectively received a percutaneous technique of ICBG were compared to patients that retrospectively received bone morphogenetic protein-2 (BMP-2). Complication rates were assessed perioperatively and up to 1 year postoperatively. Changes in Oswestry Disability Index (ODI), visual analogue scale (VAS) back, and VAS leg pain were compared. Rates of minimum clinically important difference (MCID) achievement at final follow-up for ODI, VAS back, and VAS leg scores were compared.

Results: One hundred forty-nine patients were included: 101 in the BMP-2 cohort and 48 in the ICBG cohort. The ICBG cohort demonstrated increases in intraoperative blood loss and shorter lengths of stay. ICBG patients also experienced longer operative times, though this did not reach statistical significance. No significant differences in complication or reoperation rates were identified. The ICBG cohort demonstrated greater improvements in VAS leg pain at 6-week and 12-week follow-up. No other significant differences in PROs or MCID achievement rates were identified.

Conclusion: Patients undergoing MIS TLIF with ICBG experienced clinically insignificant increases in intraoperative blood loss and did not experience increases in postoperative pain or disability. Complication and reoperation rates were similar between groups. These results suggest that ICBG is a safe option for MIS TLIF.

Citing Articles

A systematic review of bone graft products used in lumbar interbody fusion procedures for degenerative disc disease.

Fitzgerald A, McCool R, Carr E, Miller P, Reddish K, Lohr C N Am Spine Soc J. 2025; 21:100579.

PMID: 39917175 PMC: 11800106. DOI: 10.1016/j.xnsj.2024.100579.


Bone Grafting Options for Single-Level TLIF: So Many Options, What Is the Evidence?.

Kim E, Brennan M, Margabandu P, Oska N, Robles M, Rademacher A Int J Spine Surg. 2023; 17(S3):S53-S60.

PMID: 38124018 PMC: 10753332. DOI: 10.14444/8561.


Comparative Analysis of ABM/P-15, Bone Morphogenic Protein and Demineralized Bone Matrix after Instrumented Lumbar Interbody Fusion.

Sathe A, Lee S, Kim S, Eun S, Choi Y, Lee S J Korean Neurosurg Soc. 2022; 65(6):825-833.

PMID: 35574583 PMC: 9666240. DOI: 10.3340/jkns.2021.0296.


Efficacy for Whitlockite for Augmenting Spinal Fusion.

Kwon S, Shim J, Kim Y, Lim C, An S, Han I Int J Mol Sci. 2021; 22(23).

PMID: 34884680 PMC: 8657587. DOI: 10.3390/ijms222312875.


Autologous Bone Grafting in Trauma and Orthopaedic Surgery: An Evidence-Based Narrative Review.

Migliorini F, Cuozzo F, Torsiello E, Spiezia F, Oliva F, Maffulli N J Clin Med. 2021; 10(19).

PMID: 34640364 PMC: 8509778. DOI: 10.3390/jcm10194347.


References
1.
Jang J, Lee S . Minimally invasive transforaminal lumbar interbody fusion with ipsilateral pedicle screw and contralateral facet screw fixation. J Neurosurg Spine. 2005; 3(3):218-23. DOI: 10.3171/spi.2005.3.3.0218. View

2.
Holly L, Schwender J, Rouben D, Foley K . Minimally invasive transforaminal lumbar interbody fusion: indications, technique, and complications. Neurosurg Focus. 2006; 20(3):E6. DOI: 10.3171/foc.2006.20.3.7. View

3.
Park J, Bae Y, Suh S, Yang J, Hong J . Efficacy of cortico/cancellous composite allograft in treatment of cervical spondylosis. Medicine (Baltimore). 2017; 96(33):e7803. PMC: 5571711. DOI: 10.1097/MD.0000000000007803. View

4.
Than K, Rahman S, McKeever P, Wang A, La Marca F, Park P . Symptomatic calcified perineural cyst after use of bone morphogenetic protein in transforaminal lumbar interbody fusion: a case report. Spine J. 2013; 13(8):e31-5. DOI: 10.1016/j.spinee.2013.05.020. View

5.
Ahn J, Tabaraee E, Singh K . Minimally Invasive Transforaminal Lumbar Interbody Fusion. J Spinal Disord Tech. 2015; 28(6):222-5. DOI: 10.1097/BSD.0000000000000289. View